Dr. Jeffrey Schweitzer to Host Webinar on Treatment Options for Essential Tremor and Parkinson's Disease
Lalji-Student-Scholar-Award-2023. Lalji-Student-Scholar-Award-2023. Boston- The Sean. M. Healey & AMG Center for ALS at Massachusetts General Hospital through the generosity of Drs. Shelena and Ayeez Lalji, is delighted to announce that Deland Liu,
Hakan Ay, MD, a stroke physician and an investigator in the department of Radiology is the senior author of a recently published paper in Annals of Neurology, Stroke-Related Visceral Alterations: A Voxel-Based Neuroanatomic Localization Study
Validating-an-MRI-Biomarker-for-Early-Onset-Alzheimers-Disease. Validating-an-MRI-Biomarker-for-Early-Onset-Alzheimers-Disease. Headshot template Alexandra Touroutoglou, PhD and Bradford Dickerson, MD, neuroscientists in the department of Neurology
Jonathan Rosand, MD, MSC, presented the McCance Center’s strategy, strengths and progress and the Brain Care Score at the Science Summit of the 78th United Nations General Assembly meetings in New York City.
Election to the NAM is considered one of the highest honors in health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Sean M. Healey & AMG Center for ALS awarded NIH U01 Grant to support Expanded Access to Pridopidine in Collaboration with Prilenia Therapeutics
e Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital has been awarded a grant from the National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) to conduct an intermediate size Expanded Access Protocol (EAP) in Amyotrophic Lateral Sclerosis (ALS) in collaboration with Prilenia Therapeutics.
Sean M. Healey & AMG Center for ALS and the University of California, Irvine Announce First Participant Enrolled in Expanded Access Protocol Program for Trehalose
The University of California, Irvine (UCI) successfully enrolled the first participant in its newly established Expanded Access Protocol (EAP) program.
Updates on nationwide REACH study. Updates on nationwide REACH study. What is the “REACH-ICH” study? Doctors are still working to understand why some stroke survivors develop another stroke, memory problems, and depression while others do not.
Exercise-Induced Hormone Irisin May Reduce Alzheimer’s Disease Plaque and Tangle Pathology in the Brain
The findings could lead to new therapeutic strategies for the treatment of Alzheimer’s disease.
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.